| Detected | Trial | Change |
|---|---|---|
| 2026-08-01 | NCT05304767 An Extension Study to Assess Long-Term Safety and Tolerability of Adjunctive KarXT in… |
Trial completed |
| 2026-08-01 | NCT05304767 An Extension Study to Assess Long-Term Safety and Tolerability of Adjunctive KarXT in… |
Trial sites reduced: 175 -> 94 locations |
| 2026-07-23 | NCT07118215 A Study to Evaluate the Effects of KarXT on the Drug Levels of Midazolam, Fexofenadine… |
Trial completed |
| 2026-07-21 | NCT07424404 A Study to Evaluate the Long-term Safety and Tolerability of KarXT and KarX-EC for the… |
Trial sites expanded: 58 -> 95 locations |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 4 | |||
| NCT07681076 | Study to Assess Safety and Tolerability of KarXT With Administration of Antiemetics in… | Healthy Volunteers | Not Yet Recruiting |
| Phase 3 | |||
| NCT05980949 | Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in… | Psychosis Associated With Alzheimer's Disease | Recruiting |
| NCT05511363 | A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated… | Psychosis Associated With Alzheimer's Disease | Recruiting |
| NCT06126224 | A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated… | Psychosis Associated With Alzheimer's Disease | Recruiting |
| NCT06585787 | A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's… | Alzheimer Disease | Recruiting |
| NCT07424404 | A Study to Evaluate the Long-term Safety and Tolerability of KarXT and KarX-EC for the… | Schizophrenia | Recruiting |
| NCT07686263 | Relapse Prevention Trial Evaluating KarXT Treatment in Schizophrenia | Schizophrenia | Not Yet Recruiting |
| Phase 1 | |||
| NCT07204418 | A Study to Evaluate the Effects of CYP2D6 Phenotypes on the Pharmacokinetics of… | Healthy Volunteers | Recruiting |